APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neuromodulation Devices and Implantable Infusion Pumps

An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.

Selected research

Market Analysis & Forecast

Global Neuromodulation Devices and Implantable Infusion Pumps Market Analysis and Forecast 2026-2032

21 December 2025196 pages

Choose your research edition.

Industry ResearchNeuromodulation Devices and Implantable Infusion Pumps Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Neuromodulation Devices and Implantable Infusion Pumps Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Neuromodulation Devices and Implantable Infusion Pumps Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neuromodulation Devices and Implantable Infusion Pumps Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Neuromodulation Devices and Implantable Infusion Pumps Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.

In United States, Neuromodulation Devices and Implantable Infusion Pumps key players include Medtronic, Boston Scientific Corporation, St. Jude Medical, etc. Global top three manufacturers hold a share over 75%.

Midwest is the largest market, with a share about 50%, followed by South, and West, both have a share over 45 percent.

Read the full market overview

In terms of product, Spinal Cord Stimulation is the largest segment, with a share over 50%. And in terms of application, the largest application is Pain, followed by Parkinson's disease, Epilepsy, etc.

This report presents an overview of global market for Neuromodulation Devices and Implantable Infusion Pumps, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Neuromodulation Devices and Implantable Infusion Pumps, also provides the sales of main regions and countries. Of the upcoming market potential for Neuromodulation Devices and Implantable Infusion Pumps, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Neuromodulation Devices and Implantable Infusion Pumps sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Neuromodulation Devices and Implantable Infusion Pumps market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Neuromodulation Devices and Implantable Infusion Pumps sales, projected growth trends, production technology, application and end-user industry.

Neuromodulation Devices and Implantable Infusion Pumps Segment by Company

Medtronic

Boston Scientific Corporation

St. Jude Medical

Synapse Biomedical

Nevro Corporation

Neuropace

Cyberonics

Autonomic Technologies

Avery Biomedical

Greatbatch Medical

Neuromodulation Devices and Implantable Infusion Pumps Segment by Type

Spinal Cord Stimulation

Deep Brain Stimulation

Sacral Nerve Stimulation

Vagal Nerve Stimulation

Gastric Stimulation

Transcranial Magnetic Stimulation

Transcutaneous Electrical Stimulation

Other

Neuromodulation Devices and Implantable Infusion Pumps Segment by Application

Parkinson's Disease

Epilepsy

Pain

Other

Neuromodulation Devices and Implantable Infusion Pumps Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neuromodulation Devices and Implantable Infusion Pumps market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neuromodulation Devices and Implantable Infusion Pumps and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neuromodulation Devices and Implantable Infusion Pumps.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Neuromodulation Devices and Implantable Infusion Pumps in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Neuromodulation Devices and Implantable Infusion Pumps manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Neuromodulation Devices and Implantable Infusion Pumps sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Spinal Cord Stimulation Major Manufacturers Table 3. Deep Brain Stimulation Major Manufacturers Table 4. Sacral Nerve Stimulation Major Manufacturers Table 5. Vagal Nerve Stimulation Major Manufacturers Table 6. Gastric Stimulation Major Manufacturers Table 7. Transcranial Magnetic Stimulation Major Manufacturers Table 8. Transcutaneous Electrical Stimulation Major Manufacturers Table 9. Other Major Manufacturers Table 10. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 11. Parkinson's Disease Major Manufacturers Table 12. Epilepsy Major Manufacturers Table 13. Pain Major Manufacturers Table 14. Other Major Manufacturers Table 15. Neuromodulation Devices and Implantable Infusion Pumps Industry Trends Table 16. Neuromodulation Devices and Implantable Infusion Pumps Industry Drivers Table 17. Neuromodulation Devices and Implantable Infusion Pumps Industry Opportunities and Challenges Table 18. Neuromodulation Devices and Implantable Infusion Pumps Industry Restraints Table 19. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2021-2026) & (US$ Million) Table 21. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2027-2032) & (US$ Million) Table 22. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region (2021-2026) Table 23. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region (2027-2032) Table 24. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Unit) Table 25. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2021-2026) & (Unit) Table 26. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2027-2032) & (Unit) Table 27. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2021-2026) Table 28. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2027-2032) Table 29. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Manufacturers (2021-2026) Table 31. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Manufacturers (US$ Million) & (2021-2026) Table 32. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Manufacturers (2021-2026) Table 33. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 34. Global Neuromodulation Devices and Implantable Infusion Pumps Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 35. Global Neuromodulation Devices and Implantable Infusion Pumps Key Manufacturers Manufacturing Sites & Headquarters Table 36. Global Neuromodulation Devices and Implantable Infusion Pumps Manufacturers, Product Type & Application Table 37. Global Neuromodulation Devices and Implantable Infusion Pumps Manufacturers' Establishment Date Table 38. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 39. Global Neuromodulation Devices and Implantable Infusion Pumps by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2021-2026) & (US$ Million) Table 42. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2027-2032) & (US$ Million) Table 43. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2021-2026) Table 44. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2027-2032) Table 45. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type 2021 VS 2025 VS 2032 (Unit) Table 46. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026) & (Unit) Table 47. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2027-2032) & (Unit) Table 48. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2021-2026) Table 49. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2027-2032) Table 50. Global Neuromodulation Devices and Implantable Infusion Pumps Price by Type (2021-2026) & (USD/Unit) Table 51. Global Neuromodulation Devices and Implantable Infusion Pumps Price by Type (2027-2032) & (USD/Unit) Table 52. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2021-2026) & (US$ Million) Table 54. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2027-2032) & (US$ Million) Table 55. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application (2021-2026) Table 56. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application (2027-2032) Table 57. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application 2021 VS 2025 VS 2032 (Unit) Table 58. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026) & (Unit) Table 59. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2027-2032) & (Unit) Table 60. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2021-2026) Table 61. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2027-2032) Table 62. Global Neuromodulation Devices and Implantable Infusion Pumps Price by Application (2021-2026) & (USD/Unit) Table 63. Global Neuromodulation Devices and Implantable Infusion Pumps Price by Application (2027-2032) & (USD/Unit) Table 64. Medtronic Company Information Table 65. Medtronic Business Overview Table 66. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 67. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 68. Medtronic Recent Development Table 69. Boston Scientific Corporation Company Information Table 70. Boston Scientific Corporation Business Overview Table 71. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 72. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 73. Boston Scientific Corporation Recent Development Table 74. St. Jude Medical Company Information Table 75. St. Jude Medical Business Overview Table 76. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 77. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 78. St. Jude Medical Recent Development Table 79. Synapse Biomedical Company Information Table 80. Synapse Biomedical Business Overview Table 81. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 82. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 83. Synapse Biomedical Recent Development Table 84. Nevro Corporation Company Information Table 85. Nevro Corporation Business Overview Table 86. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 87. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 88. Nevro Corporation Recent Development Table 89. Neuropace Company Information Table 90. Neuropace Business Overview Table 91. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 92. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 93. Neuropace Recent Development Table 94. Cyberonics Company Information Table 95. Cyberonics Business Overview Table 96. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 97. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 98. Cyberonics Recent Development Table 99. Autonomic Technologies Company Information Table 100. Autonomic Technologies Business Overview Table 101. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 102. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 103. Autonomic Technologies Recent Development Table 104. Avery Biomedical Company Information Table 105. Avery Biomedical Business Overview Table 106. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 107. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 108. Avery Biomedical Recent Development Table 109. Greatbatch Medical Company Information Table 110. Greatbatch Medical Business Overview Table 111. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 112. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio Table 113. Greatbatch Medical Recent Development Table 114. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2021-2026) & (US$ Million) Table 115. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2027-2032) & (US$ Million) Table 116. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026) & (Unit) Table 117. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2027-2032) & (Unit) Table 118. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Price by Type (2021-2026) & (USD/Unit) Table 119. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Price by Type (2027-2032) & (USD/Unit) Table 120. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2021-2026) & (US$ Million) Table 121. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2027-2032) & (US$ Million) Table 122. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026) & (Unit) Table 123. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2027-2032) & (Unit) Table 124. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Price by Application (2021-2026) & (USD/Unit) Table 125. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Price by Application (2027-2032) & (USD/Unit) Table 126. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 128. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 129. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021 VS 2025 VS 2032) & (Unit) Table 130. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2026) & (Unit) Table 131. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2027-2032) & (Unit) Table 132. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Price by Country (2021-2026) & (USD/Unit) Table 133. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Price by Country (2027-2032) & (USD/Unit) Table 134. United States Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032) & (US$ Million) Table 135. Canada Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032) & (US$ Million) Table 136. Mexico Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032) & (US$ Million) Table 137. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2021-2026) & (US$ Million) Table 138. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2027-2032) & (US$ Million) Table 139. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026) & (Unit) Table 140. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2027-2032) & (Unit) Table 141. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Price by Type (2021-2026) & (USD/Unit) Table 142. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Price by Type (2027-2032) & (USD/Unit) Table 143. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2021-2026) & (US$ Million) Table 144. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2027-2032) & (US$ Million) Table 145. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026) & (Unit) Table 146. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2027-2032) & (Unit) Table 147. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Price by Application (2021-2026) & (USD/Unit) Table 148. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Price by Application (2027-2032) & (USD/Unit) Table 149. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 151. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 152. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021 VS 2025 VS 2032) & (Unit) Table 153. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2026) & (Unit) Table 154. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2027-2032) & (Unit) Table 155. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Price by Country (2021-2026) & (USD/Unit) Table 156. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Price by Country (2027-2032) & (USD/Unit) Table 157. Germany Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032) & (US$ Million) Table 158. France Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032) & (US$ Million) Table 159. U.K. Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032) & (US$ Million) Table 160. Italy Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032) & (US$ Million) Table 161. Russia Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032) & (US$ Million) Table 162. Spain Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032) & (US$ Million) Table 163. Netherlands Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032) & (US$ Million) Table 164. Switzerland Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032) & (US$ Million) Table 165. Sweden Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032) & (US$ Million) Table 166. Poland Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032) & (US$ Million) Table 167. China Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2021-2026) & (US$ Million) Table 168. China Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2027-2032) & (US$ Million) Table 169. China Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026) & (Unit) Table 170. China Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2027-2032) & (Unit) Table 171. China Neuromodulation Devices and Implantable Infusion Pumps Sales Price by Type (2021-2026) & (USD/Unit) Table 172. China Neuromodulation Devices and Implantable Infusion Pumps Sales Price by Type (2027-2032) & (USD/Unit) Table 173. China Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2021-2026) & (US$ Million) Table 174. China Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2027-2032) & (US$ Million) Table 175. China Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026) & (Unit) Table 176. China Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2027-2032) & (Unit) Table 177. China Neuromodulation Devices and Implantable Infusion Pumps Sales Price by Application (2021-2026) & (USD/Unit) Table 178. China Neuromodulation Devices and Implantable Infusion Pumps Sales Price by Application (2027-2032) & (USD/Unit) Table 179. Asia Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2021-2026) & (US$ Million) Table 180. Asia Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2027-2032) & (US$ Million) Table 181. Asia Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026) & (Unit) Table 182. Asia Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2027-2032) & (Unit) Table 183. Asia Neuromodulation Devices and Implantable Infusion Pumps Sales Price by Type (2021-2026) & (USD/Unit) Table 184. Asia Neuromodulation Devices and Implantable Infusion Pumps Sales Price by Type (2027-2032) & (USD/Unit) Table 185. Asia Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2021-2026) & (US$ Million) Table 186. Asia Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2027-2032) & (US$ Million) Table 187. Asia Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026) & (Unit) Table 188. Asia Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2027-2032) & (Unit) Table 189. Asia Neuromodulation Devices and Implantable Infusion Pumps Sales Price by Application (2021-2026) & (USD/Unit) Table 190. Asia Neuromodulation Devices and Implantable Infusion Pumps Sales Price by Application (2027-2032) & (USD/Unit) Table 191. Asia Neuromodulation Devices and Implantable Infusion Pumps Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 192. Asia Neuromodulation Devices and Implantable Infusion Pumps Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 193. Asia Neuromodulation Devices and Implantable Infusion Pumps Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 194. Asia Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021 VS 2025 VS 2032) & (Unit) Table 195. Asia Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2026) & (Unit) Table 196. Asia Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2027-2032) & (Unit) Table 197. Asia Neuromodulation Devices and Implantable Infusion Pumps Sales Price by Country (2021-2026) & (USD/Unit) Table 198. Asia Neuromodulation Devices and Implantable Infusion Pumps Sales Price by Country (2027-2032) & (USD/Unit) Table 199. Japan Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032) & (US$ Million) Table 200. South Korea Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032) & (US$ Million) Table 201. India Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032) & (US$ Million) Table 202. Australia Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032) & (US$ Million) Table 203. Taiwan Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032) & (US$ Million) Table 204. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032) & (US$ Million) Table 205. SAMEA Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2021-2026) & (US$ Million) Table 206. SAMEA Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2027-2032) & (US$ Million) Table 207. SAMEA Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2026) & (Unit) Table 208. SAMEA Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2027-2032) & (Unit) Table 209. SAMEA Neuromodulation Devices and Implantable Infusion Pumps Sales Price by Type (2021-2026) & (USD/Unit) Table 210. SAMEA Neuromodulation Devices and Implantable Infusion Pumps Sales Price by Type (2027-2032) & (USD/Unit) Table 211. SAMEA Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2021-2026) & (US$ Million) Table 212. SAMEA Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2027-2032) & (US$ Million) Table 213. SAMEA Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2026) & (Unit) Table 214. SAMEA Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2027-2032) & (Unit) Table 215. SAMEA Neuromodulation Devices and Implantable Infusion Pumps Sales Price by Application (2021-2026) & (USD/Unit) Table 216. SAMEA Neuromodulation Devices and Implantable Infusion Pumps Sales Price by Application (2027-2032) & (USD/Unit) Table 217. SAMEA Neuromodulation Devices and Implantable Infusion Pumps Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 218. SAMEA Neuromodulation Devices and Implantable Infusion Pumps Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 219. SAMEA Neuromodulation Devices and Implantable Infusion Pumps Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 220. SAMEA Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021 VS 2025 VS 2032) & (Unit) Table 221. SAMEA Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021-2026) & (Unit) Table 222. SAMEA Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2027-2032) & (Unit) Table 223. SAMEA Neuromodulation Devices and Implantable Infusion Pumps Sales Price by Country (2021-2026) & (USD/Unit) Table 224. SAMEA Neuromodulation Devices and Implantable Infusion Pumps Sales Price by Country (2027-2032) & (USD/Unit) Table 225. Brazil Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032) & (US$ Million) Table 226. Argentina Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032) & (US$ Million) Table 227. Chile Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032) & (US$ Million) Table 228. Colombia Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032) & (US$ Million) Table 229. Peru Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032) & (US$ Million) Table 230. Saudi Arabia Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032) & (US$ Million) Table 231. Israel Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032) & (US$ Million) Table 232. UAE Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032) & (US$ Million) Table 233. Turkey Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032) & (US$ Million) Table 234. Iran Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032) & (US$ Million) Table 235. Egypt Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032) & (US$ Million) Table 236. Key Raw Materials Table 237. Raw Materials Key Suppliers Table 238. Neuromodulation Devices and Implantable Infusion Pumps Distributors List Table 239. Neuromodulation Devices and Implantable Infusion Pumps Customers List Table 240. Research Programs/Design for This Report Table 241. Authors List of This Report Table 242. Secondary Sources Table 243. Primary Sources List of Figures Figure 1. Neuromodulation Devices and Implantable Infusion Pumps Image Figure 2. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Share 2021 VS 2025 VS 2032 Figure 4. Spinal Cord Stimulation Image Figure 5. Deep Brain Stimulation Image Figure 6. Sacral Nerve Stimulation Image Figure 7. Vagal Nerve Stimulation Image Figure 8. Gastric Stimulation Image Figure 9. Transcranial Magnetic Stimulation Image Figure 10. Transcutaneous Electrical Stimulation Image Figure 11. Other Image Figure 12. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Share 2021 VS 2025 VS 2032 Figure 14. Parkinson's Disease Image Figure 15. Epilepsy Image Figure 16. Pain Image Figure 17. Other Image Figure 18. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue (2021-2032) & (US$ Million) Figure 20. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region: 2025 Versus 2032 Figure 22. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region (2021-2032) Figure 23. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (2021-2032) & (Unit) Figure 24. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region: 2021 VS 2025 VS 2032 (Unit) Figure 25. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2021-2032) Figure 26. US & Canada & Mexico Neuromodulation Devices and Implantable Infusion Pumps Sales YoY (2021-2032) & (Unit) Figure 27. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales YoY (2021-2032) & (Unit) Figure 28. China Neuromodulation Devices and Implantable Infusion Pumps Sales YoY (2021-2032) & (Unit) Figure 29. Asia (Excluding China) Neuromodulation Devices and Implantable Infusion Pumps Sales YoY (2021-2032) & (Unit) Figure 30. South America, Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales YoY (2021-2032) & (Unit) Figure 31. Global Neuromodulation Devices and Implantable Infusion Pumps Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 32. Global Neuromodulation Devices and Implantable Infusion Pumps Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 33. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 34. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2021-2032) Figure 37. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021 VS 2025 VS 2032) & (Unit) Figure 38. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 39. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2021-2032) Figure 40. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 41. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application (2021-2032) Figure 43. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021 VS 2025 VS 2032) & (Unit) Figure 44. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 45. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2021-2032) Figure 46. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Type (2021-2032) Figure 47. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Type (2021-2032) Figure 48. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Application (2021-2032) Figure 49. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Application (2021-2032) Figure 50. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Country (2021-2032) Figure 51. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Country (2021-2032) Figure 52. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Type (2021-2032) Figure 53. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Type (2021-2032) Figure 54. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Application (2021-2032) Figure 55. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Application (2021-2032) Figure 56. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Country (2021-2032) Figure 57. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Country (2021-2032) Figure 58. China Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Type (2021-2032) Figure 59. China Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Type (

Scope & coverage.

Types
  • Spinal Cord Stimulation
  • Deep Brain Stimulation
  • Sacral Nerve Stimulation
  • Vagal Nerve Stimulation
  • Gastric Stimulation
  • Transcranial Magnetic Stimulation
  • Transcutaneous Electrical Stimulation
  • Other
Applications
  • Parkinson's Disease
  • Epilepsy
  • Pain
  • Other
Companies covered
  • Medtronic
  • Boston Scientific Corporation
  • St. Jude Medical
  • Synapse Biomedical
  • Nevro Corporation
  • Neuropace
  • Cyberonics
  • Autonomic Technologies
  • Avery Biomedical
  • Greatbatch Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Neuromodulation Devices and Implantable Infusion Pumps Market by Type
  3. 1.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Spinal Cord Stimulation
  5. 1.2.3 Deep Brain Stimulation
  6. 1.2.4 Sacral Nerve Stimulation
  7. 1.2.5 Vagal Nerve Stimulation
  8. 1.2.6 Gastric Stimulation
  9. 1.2.7 Transcranial Magnetic Stimulation
  10. 1.2.8 Transcutaneous Electrical Stimulation
  11. 1.2.9 Other
  12. 1.3 Neuromodulation Devices and Implantable Infusion Pumps Market by Application
  13. 1.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size by Application, 2021 VS 2025 VS 2032
  14. 1.3.2 Parkinson's Disease
  15. 1.3.3 Epilepsy
  16. 1.3.4 Pain
  17. 1.3.5 Other
  18. 1.4 Assumptions and Limitations
  19. 1.5 Study Goals and Objectives
2 Neuromodulation Devices and Implantable Infusion Pumps Market Dynamics
  1. 2.1 Neuromodulation Devices and Implantable Infusion Pumps Industry Trends
  2. 2.2 Neuromodulation Devices and Implantable Infusion Pumps Industry Drivers
  3. 2.3 Neuromodulation Devices and Implantable Infusion Pumps Industry Opportunities and Challenges
  4. 2.4 Neuromodulation Devices and Implantable Infusion Pumps Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region
  3. 3.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2021-2026)
  5. 3.2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2027-2032)
  6. 3.2.4 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region
  9. 3.4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2021-2026)
  11. 3.4.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2027-2032)
  12. 3.4.4 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Manufacturers
  2. 4.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Neuromodulation Devices and Implantable Infusion Pumps Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Manufacturers
  6. 4.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Neuromodulation Devices and Implantable Infusion Pumps Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Neuromodulation Devices and Implantable Infusion Pumps Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Neuromodulation Devices and Implantable Infusion Pumps Manufacturers, Product Type & Application
  13. 4.7 Global Neuromodulation Devices and Implantable Infusion Pumps Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market CR5 and HHI
  16. 4.8.2 2025 Neuromodulation Devices and Implantable Infusion Pumps Tier 1, Tier 2, and Tier 3
5 Neuromodulation Devices and Implantable Infusion Pumps Market by Type
  1. 5.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type
  2. 5.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type
  6. 5.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2032) & (Unit)
  8. 5.2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2021-2032)
  9. 5.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Type
6 Neuromodulation Devices and Implantable Infusion Pumps Market by Application
  1. 6.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application
  2. 6.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application
  6. 6.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2032) & (Unit)
  8. 6.2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2021-2032)
  9. 6.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Application
7 Company Profiles
  1. 7.1 Medtronic
  2. 7.1.1 Medtronic Company Information
  3. 7.1.2 Medtronic Business Overview
  4. 7.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  6. 7.1.5 Medtronic Recent Developments
  7. 7.2 Boston Scientific Corporation
  8. 7.2.1 Boston Scientific Corporation Company Information
  9. 7.2.2 Boston Scientific Corporation Business Overview
  10. 7.2.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  12. 7.2.5 Boston Scientific Corporation Recent Developments
  13. 7.3 St. Jude Medical
  14. 7.3.1 St. Jude Medical Company Information
  15. 7.3.2 St. Jude Medical Business Overview
  16. 7.3.3 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  18. 7.3.5 St. Jude Medical Recent Developments
  19. 7.4 Synapse Biomedical
  20. 7.4.1 Synapse Biomedical Company Information
  21. 7.4.2 Synapse Biomedical Business Overview
  22. 7.4.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  24. 7.4.5 Synapse Biomedical Recent Developments
  25. 7.5 Nevro Corporation
  26. 7.5.1 Nevro Corporation Company Information
  27. 7.5.2 Nevro Corporation Business Overview
  28. 7.5.3 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  30. 7.5.5 Nevro Corporation Recent Developments
  31. 7.6 Neuropace
  32. 7.6.1 Neuropace Company Information
  33. 7.6.2 Neuropace Business Overview
  34. 7.6.3 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  36. 7.6.5 Neuropace Recent Developments
  37. 7.7 Cyberonics
  38. 7.7.1 Cyberonics Company Information
  39. 7.7.2 Cyberonics Business Overview
  40. 7.7.3 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  42. 7.7.5 Cyberonics Recent Developments
  43. 7.8 Autonomic Technologies
  44. 7.8.1 Autonomic Technologies Company Information
  45. 7.8.2 Autonomic Technologies Business Overview
  46. 7.8.3 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  48. 7.8.5 Autonomic Technologies Recent Developments
  49. 7.9 Avery Biomedical
  50. 7.9.1 Avery Biomedical Company Information
  51. 7.9.2 Avery Biomedical Business Overview
  52. 7.9.3 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  54. 7.9.5 Avery Biomedical Recent Developments
  55. 7.10 Greatbatch Medical
  56. 7.10.1 Greatbatch Medical Company Information
  57. 7.10.2 Greatbatch Medical Business Overview
  58. 7.10.3 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
  60. 7.10.5 Greatbatch Medical Recent Developments
8 North America
  1. 8.1 North America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Type
  2. 8.1.1 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2021-2032)
  3. 8.1.2 North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2032)
  4. 8.1.3 North America Neuromodulation Devices and Implantable Infusion Pumps Price by Type (2021-2032)
  5. 8.2 North America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Application
  6. 8.2.1 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2021-2032)
  7. 8.2.2 North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2032)
  8. 8.2.3 North America Neuromodulation Devices and Implantable Infusion Pumps Price by Application (2021-2032)
  9. 8.3 North America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country
  10. 8.3.1 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Neuromodulation Devices and Implantable Infusion Pumps Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size by Type
  2. 9.1.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2021-2032)
  3. 9.1.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2032)
  4. 9.1.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Price by Type (2021-2032)
  5. 9.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size by Application
  6. 9.2.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2021-2032)
  7. 9.2.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2032)
  8. 9.2.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Price by Application (2021-2032)
  9. 9.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country
  10. 9.3.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Neuromodulation Devices and Implantable Infusion Pumps Market Size by Type
  2. 10.1.1 China Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2021-2032)
  3. 10.1.2 China Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2032)
  4. 10.1.3 China Neuromodulation Devices and Implantable Infusion Pumps Price by Type (2021-2032)
  5. 10.2 China Neuromodulation Devices and Implantable Infusion Pumps Market Size by Application
  6. 10.2.1 China Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2021-2032)
  7. 10.2.2 China Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2032)
  8. 10.2.3 China Neuromodulation Devices and Implantable Infusion Pumps Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Neuromodulation Devices and Implantable Infusion Pumps Market Size by Type
  2. 11.1.1 Asia Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2021-2032)
  3. 11.1.2 Asia Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2032)
  4. 11.1.3 Asia Neuromodulation Devices and Implantable Infusion Pumps Price by Type (2021-2032)
  5. 11.2 Asia Neuromodulation Devices and Implantable Infusion Pumps Market Size by Application
  6. 11.2.1 Asia Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2021-2032)
  7. 11.2.2 Asia Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2032)
  8. 11.2.3 Asia Neuromodulation Devices and Implantable Infusion Pumps Price by Application (2021-2032)
  9. 11.3 Asia Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country
  10. 11.3.1 Asia Neuromodulation Devices and Implantable Infusion Pumps Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Neuromodulation Devices and Implantable Infusion Pumps Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Neuromodulation Devices and Implantable Infusion Pumps Market Size by Type
  2. 12.1.1 SAMEA Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Neuromodulation Devices and Implantable Infusion Pumps Price by Type (2021-2032)
  5. 12.2 SAMEA Neuromodulation Devices and Implantable Infusion Pumps Market Size by Application
  6. 12.2.1 SAMEA Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Neuromodulation Devices and Implantable Infusion Pumps Price by Application (2021-2032)
  9. 12.3 SAMEA Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country
  10. 12.3.1 SAMEA Neuromodulation Devices and Implantable Infusion Pumps Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Neuromodulation Devices and Implantable Infusion Pumps Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Neuromodulation Devices and Implantable Infusion Pumps Value Chain Analysis
  2. 13.1.1 Neuromodulation Devices and Implantable Infusion Pumps Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Neuromodulation Devices and Implantable Infusion Pumps Production Mode & Process
  6. 13.2 Neuromodulation Devices and Implantable Infusion Pumps Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Neuromodulation Devices and Implantable Infusion Pumps Distributors
  9. 13.2.3 Neuromodulation Devices and Implantable Infusion Pumps Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst